Parkinson’s disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddag103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von An Phu Tran Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Science, Van Andel Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, United States. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, rab GTP-Binding Proteins. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Van Andel Institute, NIH HHS.
Abstract (Originalsprache)
Mutations in the LRRK2 gene are the most frequent cause of familial Parkinson’s disease (PD) whereas common variants are associated with an increased risk for sporadic PD. LRRK2 encodes a multi-domain protein displaying two functional enzymatic activities: GTPase and kinase. In addition to familial mutations, several common LRRK2 coding variants have been associated with PD risk in different ethnic populations. Little is known about how these coding variants modulate the risk of developing PD. In this study, we aimed to evaluate the properties of a collection of LRRK2 coding risk variants (A419V, N551K, R1398H, R1628P, M1646T, S1647T, G2385R). With the exception of G2385R, we find that coding risk variants have minimal impact on LRRK2 protein levels, GTP-binding, LRRK2 phosphorylation, and subcellular localization in human cells and primary neurons. G2385R LRRK2 exhibits reduced phosphorylation at Ser910/Ser935 and Ser1292, consistent with diminished kinase activity. Notably, however, LRRK2 variants associated with increased PD risk (R1628P, M1646T, and G2385R) significantly elevate the levels of LRRK2-mediated Rab10 phosphorylation by >two-fold in cells. In contrast, LRRK2 variants associated with reduced PD risk (N551K, R1398H, and N551K-R1398H) do not alter pRab10 levels. The G2385R LRRK2 variant significantly inhibits neurite outgrowth in primary cortical neurons compared to wild-type LRRK2. Our study indicates that LRRK2-dependent Rab phosphorylation represents a relevant readout of PD risk induced by LRRK2 variants and demonstrates that the G2385R variant creates a hyperactive kinase that can impair neuronal integrity at comparable levels to the effects of G2019S LRRK2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodegenerative Science, Van Andel Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, United States.
- Department of Biological Sciences, University of Wisconsin-Milwaukee, 3209 N. Maryland Ave, Milwaukee, WI 53211, United States.
- Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, Swiss Federal Institute of Technology (EPFL), Route Cantonale, Lausanne 1015, Switzerland.
- Center for Neurodegeneration and Neurotherapeutics, Duke University, 3 Genome Court, Durham, NC 27710, United States.
- Department of Structural Biology, Van Andel Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, United States.
ORCID-Profile: Darren J Moore
Förderung
- NINDS NIH HHS
- Van Andel Institute
- NIH HHS
- National Institutes of Health
Zitieren
APA
Nguyen, A. P. T., Moser, R., Bryant, N., Cunningham, L. A., Worden, E. J., & Moore, D. J. (2026). Parkinson’s disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddag103
Vancouver
Nguyen APT, Moser R, Bryant N, Cunningham LA, Worden EJ, Moore DJ. Parkinson’s disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddag103
BibTeX
@article{Nguyen2026,
author = {Nguyen, An Phu Tran and Moser, Roger and Bryant, Nicole and Cunningham, Lindsey A and Worden, Evan J and Moore, Darren J},
title = {Parkinson’s disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddag103}
}
EUVIMED